Impact on Waist Circumference & Fat Distribution Research also shows that GLP-1 medications help reduce: Visceral fat (fat around the organs) Liver fat (in patients with fatty liver, NAFLD) Waist size and abdominal fat mass These improvements support cardiovascular health and metabolic stability, not just weight loss
The second indication is chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity such as hypertension, dyslipidemia, or obstructive sleep apnea
Preparing for an Injection Describe any symptoms you've been experiencing to your doctor, especially things like mental fogginess and overall fatigue, so your doctor can make an assessment
M., Dudziec, E., Peter, S., Bertz, S., Hartmann, A., Bryant, H
H.RosiB
Bibcode:2000PNAS...9711256Y